Monday, October 26, 2026 · Daily editionET --:--:--

Looking for volunteers

Study of Wearable Interventions for Improving Mobility of Individuals With Knee Osteoarthritis

NCT07652437 · Massachusetts Institute of Technology · Updated 17 June 2026

What is being tested
Dephy Exoboot
For
Knee Osteoarthristis
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 21 years to 100 years. About 9 people. The full rules are on the registry page.
Where
United States
When
Starts or started 15 Dec 2025, ends 1 July 2029. Registered 17 June 2026.
Results
None posted yet.

In the researchers' words

Knee osteoarthritis (OA) affects an estimated 654 million people over age 40 world-wide. In the United States, approximately 16% of adults over the age of 40 have knee OA. Pain, activity limitations and disability are common symptoms. Exercise is widely recommended as a non-invasive, first line strategy for people with knee OA. Yet, less than 1/3 of adults with knee OA meet recommended levels of physical activity, and rates are even lower among people who are overweight. Furthermore, adherence to evidence-based structured programs is poor once the therapeutic support is removed. End stage disease is treated by total joint replacement. Under-active people with knee OA would benefit from general walking activity, even if joint replacement surgery is expected; however, walking is difficult and motivation is low. Thus, people with knee OA encounter a difficult paradox: exercise could help decrease pain and improve function but doing so can be difficult and may not always be possible. There is a tremendous need to address this situation. This is a small device-feasibility study evaluating the Dephy ExoBoot, a wearable powered exoskeleton, in individuals with knee OA. The study assesses whether the device can reliably deliver positive assistance during walking and is tolerated across walking tasks. Additional measures, including changes in knee loading and walking speed with versus…
ClinicalTrials.gov, NCT07652437

Sites

  • MIT Media LabCambridge, Massachusetts, United States